Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
HK$ 1.56
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Honliv Healthcare Management Group Company Limited owns and operates a general hospital in Mainland China. The company provides medical and pharmaceutical services, and hospital management services. It also operates as the pharmaceutical wholesaler. As of December 31, 2021, the company operated and managed Henan Honliv Hospital with 1,500 beds in operation located in Henan Province....
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITDA,
Data is available to registered users only
Buy
Sell